Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Cipla-Alvotech Prime Emerging Markets Push With Humira Biosimilar Deal

Mon, 07/29/2019 - 7:56am

Cipla has firmed up a commercialization deal with Alvotech for the Icelandic developer’s high-concentration version of AbbVie’s Humira, continuing to...

      Related Stories 

Pipeline Watch: Phase III Starts For Pamrevlumab, Inclisiran And OC-01

Mon, 07/29/2019 - 7:35am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Deciphering E-Pharmacy Discounts For Novartis’s Ceritinib In India

Sun, 07/28/2019 - 10:55pm

Novartis’s anticancer Spexib was being offered at a hefty 69% discount to patients in India, highlighting what some experts suggest...

      Related Stories 

Korea Races For IPF Drug Development Amid Keen Global Interest

Sun, 07/28/2019 - 10:13pm

Following major global licensing out deals in the sector this year by South Korean bioventures Bridge Biotherapeutics and TiumBio, Scrip...

      Related Stories 

AbbVie’s Five Biggest Priorities, Apart From Allergan

Fri, 07/26/2019 - 12:48pm

While it works on merging with Allergan, AbbVie is tracking biosimilar sales erosion to Humira, the promising launch of Skyrizi...

      Related Stories 

Amgen's Murdo Gordon On Generating Sales Growth In A Challenging Commercial Year

Fri, 07/26/2019 - 11:42am

Newer products are gaining ground, but not fast enough to replace sales as blockbuster products face competition. Scrip spoke with...

      Related Stories 

GW Pharma’s Cannabidiol For Seizures One Step Closer To European Approval

Fri, 07/26/2019 - 6:59am

The CHMP has issued a positive opinion for Epidyolex for two rare conditions. The cannabidiol product was approved in the...

      Related Stories 

Sawai Eyes Global Position Helped by Japan Growth And Upsher-Smith – But No Biosimilars

Thu, 07/25/2019 - 5:21pm

In an exclusive interview, the president of Japan’s largest generics company relates his strategy for success, including internal expertise in...

      Related Stories 

Pharma Execs Say Senate Drug Pricing Bill Targets Industry, Not The Problem

Thu, 07/25/2019 - 1:18pm

Industry CEOs expressed reservations about the US drug pricing legislation in the Senate, but said they support reforms that will...

      Related Stories 

Roche Raises Outlook Despite US Biosimilars, Sees Spark Buy By Year-End

Thu, 07/25/2019 - 10:42am

Roche presented a strong first-half performance and raised its outlook again for the full year as sales continued to be...

      Related Stories 

AZ On The Rise In All Regions And Therapy Areas

Thu, 07/25/2019 - 8:21am

The drug major's Q2 sales soared past consensus forecasts, driven by its three soon-to-be oncology blockbusters – Tagrisso, Imfinzi and...

      Related Stories 

Eyes On Divestments, Revised Guidance Ahead Of Takeda's Q1

Wed, 07/24/2019 - 10:54pm

As Takeda prepares to report its first full quarter post-Shire next week, eyes will be on further strategic divestments and...

      Related Stories 

Merck Positions MK-8591 As Backbone For HIV Treatment And Prophylaxis

Wed, 07/24/2019 - 12:53pm

First-in-class antiviral could be a potential backbone for combo regimens and entry into PrEP. New data releases at IAS highlight...

      Related Stories